WO2006048879A1 - Copper containing materials for treating wounds, burns and other skin conditions - Google Patents
Copper containing materials for treating wounds, burns and other skin conditions Download PDFInfo
- Publication number
- WO2006048879A1 WO2006048879A1 PCT/IL2005/001160 IL2005001160W WO2006048879A1 WO 2006048879 A1 WO2006048879 A1 WO 2006048879A1 IL 2005001160 W IL2005001160 W IL 2005001160W WO 2006048879 A1 WO2006048879 A1 WO 2006048879A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ions
- fibers
- contact
- release
- fluid
- Prior art date
Links
- 239000000463 material Substances 0.000 title claims abstract description 91
- 206010052428 Wound Diseases 0.000 title claims description 37
- 208000027418 Wounds and injury Diseases 0.000 title claims description 32
- 239000010949 copper Substances 0.000 title description 61
- 229910052802 copper Inorganic materials 0.000 title description 50
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 title description 46
- 239000005749 Copper compound Substances 0.000 claims abstract description 91
- 150000001880 copper compounds Chemical class 0.000 claims abstract description 91
- 239000012530 fluid Substances 0.000 claims abstract description 90
- 238000000034 method Methods 0.000 claims abstract description 69
- 238000011282 treatment Methods 0.000 claims abstract description 58
- 230000003902 lesion Effects 0.000 claims abstract description 49
- 208000025865 Ulcer Diseases 0.000 claims abstract description 48
- 230000035876 healing Effects 0.000 claims abstract description 44
- 238000005299 abrasion Methods 0.000 claims abstract description 40
- 230000036269 ulceration Effects 0.000 claims abstract description 34
- 208000004898 Herpes Labialis Diseases 0.000 claims abstract description 30
- 206010067152 Oral herpes Diseases 0.000 claims abstract description 29
- 230000000694 effects Effects 0.000 claims abstract description 12
- 150000002500 ions Chemical class 0.000 claims abstract description 10
- 230000001747 exhibiting effect Effects 0.000 claims abstract description 3
- 239000000835 fiber Substances 0.000 claims description 257
- -1 Cu+ ions Chemical class 0.000 claims description 191
- 239000002245 particle Substances 0.000 claims description 125
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical class [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 claims description 87
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 64
- 238000004519 manufacturing process Methods 0.000 claims description 54
- 239000004744 fabric Substances 0.000 claims description 45
- 150000001875 compounds Chemical class 0.000 claims description 31
- 206010012601 diabetes mellitus Diseases 0.000 claims description 22
- 229920000728 polyester Polymers 0.000 claims description 20
- 208000004210 Pressure Ulcer Diseases 0.000 claims description 15
- 230000029663 wound healing Effects 0.000 claims description 15
- 230000015572 biosynthetic process Effects 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 230000000844 anti-bacterial effect Effects 0.000 claims description 12
- 230000000474 nursing effect Effects 0.000 claims description 11
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 9
- 239000004952 Polyamide Substances 0.000 claims description 9
- 206010000496 acne Diseases 0.000 claims description 9
- 229920002647 polyamide Polymers 0.000 claims description 9
- 229920001281 polyalkylene Polymers 0.000 claims description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 7
- 238000005469 granulation Methods 0.000 claims description 7
- 230000003179 granulation Effects 0.000 claims description 7
- 206010011985 Decubitus ulcer Diseases 0.000 claims description 6
- 210000003414 extremity Anatomy 0.000 claims description 6
- 230000036541 health Effects 0.000 claims description 6
- 239000003356 suture material Substances 0.000 claims description 6
- 231100000397 ulcer Toxicity 0.000 claims description 6
- 201000004681 Psoriasis Diseases 0.000 claims description 5
- 210000002445 nipple Anatomy 0.000 claims description 5
- 231100000216 vascular lesion Toxicity 0.000 claims description 5
- 201000004624 Dermatitis Diseases 0.000 claims description 4
- 208000001688 Herpes Genitalis Diseases 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 4
- 230000001070 adhesive effect Effects 0.000 claims description 4
- 208000010668 atopic eczema Diseases 0.000 claims description 4
- 201000004946 genital herpes Diseases 0.000 claims description 4
- 230000001681 protective effect Effects 0.000 claims description 4
- 210000001217 buttock Anatomy 0.000 claims description 3
- 230000009854 mucosal lesion Effects 0.000 claims description 3
- 239000011148 porous material Substances 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 2
- 239000004753 textile Substances 0.000 description 43
- 125000002091 cationic group Chemical group 0.000 description 36
- 239000005751 Copper oxide Substances 0.000 description 35
- 229910000431 copper oxide Inorganic materials 0.000 description 35
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 34
- 239000010408 film Substances 0.000 description 33
- 239000000203 mixture Substances 0.000 description 27
- 229920000642 polymer Polymers 0.000 description 27
- 230000008569 process Effects 0.000 description 25
- 239000000758 substrate Substances 0.000 description 24
- 229910052751 metal Inorganic materials 0.000 description 23
- 239000002184 metal Substances 0.000 description 23
- 150000001768 cations Chemical class 0.000 description 19
- 239000000047 product Substances 0.000 description 19
- 230000006872 improvement Effects 0.000 description 17
- 210000002683 foot Anatomy 0.000 description 16
- 238000007747 plating Methods 0.000 description 15
- 239000002002 slurry Substances 0.000 description 15
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical compound [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 description 14
- 239000003638 chemical reducing agent Substances 0.000 description 13
- 229910000510 noble metal Inorganic materials 0.000 description 13
- 239000000843 powder Substances 0.000 description 12
- 239000004594 Masterbatch (MB) Substances 0.000 description 10
- 229920002678 cellulose Polymers 0.000 description 10
- 239000001913 cellulose Substances 0.000 description 10
- 230000003647 oxidation Effects 0.000 description 10
- 238000007254 oxidation reaction Methods 0.000 description 10
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 9
- 230000000845 anti-microbial effect Effects 0.000 description 9
- 230000009467 reduction Effects 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 229920000742 Cotton Polymers 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 8
- 239000004743 Polypropylene Substances 0.000 description 8
- 229920001155 polypropylene Polymers 0.000 description 8
- 229920003043 Cellulose fiber Polymers 0.000 description 7
- 206010015150 Erythema Diseases 0.000 description 7
- 241000700605 Viruses Species 0.000 description 7
- 230000000840 anti-viral effect Effects 0.000 description 7
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 7
- 150000002739 metals Chemical class 0.000 description 7
- 229920000098 polyolefin Polymers 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 238000002791 soaking Methods 0.000 description 7
- 241000894007 species Species 0.000 description 7
- 229920002972 Acrylic fiber Polymers 0.000 description 6
- 229910000323 aluminium silicate Inorganic materials 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 229910000365 copper sulfate Inorganic materials 0.000 description 6
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 6
- 231100000321 erythema Toxicity 0.000 description 6
- 230000002779 inactivation Effects 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 239000007800 oxidant agent Substances 0.000 description 6
- 230000001590 oxidative effect Effects 0.000 description 6
- 229920006306 polyurethane fiber Polymers 0.000 description 6
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 6
- 229920002554 vinyl polymer Polymers 0.000 description 6
- 239000004698 Polyethylene Substances 0.000 description 5
- 206010037898 Rash vesicular Diseases 0.000 description 5
- 238000001125 extrusion Methods 0.000 description 5
- 229920000573 polyethylene Polymers 0.000 description 5
- 229920006297 regenerated protein fiber Polymers 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 4
- 150000001879 copper Chemical class 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000007803 itching Effects 0.000 description 4
- 229910044991 metal oxide Inorganic materials 0.000 description 4
- 150000004706 metal oxides Chemical class 0.000 description 4
- 230000006911 nucleation Effects 0.000 description 4
- 238000010899 nucleation Methods 0.000 description 4
- 229920001778 nylon Polymers 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 206010033892 Paraplegia Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000000843 anti-fungal effect Effects 0.000 description 3
- 229940121375 antifungal agent Drugs 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- BERDEBHAJNAUOM-UHFFFAOYSA-N copper(I) oxide Inorganic materials [Cu]O[Cu] BERDEBHAJNAUOM-UHFFFAOYSA-N 0.000 description 3
- KRFJLUBVMFXRPN-UHFFFAOYSA-N cuprous oxide Chemical compound [O-2].[Cu+].[Cu+] KRFJLUBVMFXRPN-UHFFFAOYSA-N 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000006479 redox reaction Methods 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 229920002994 synthetic fiber Polymers 0.000 description 3
- 239000012209 synthetic fiber Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 2
- 229920002292 Nylon 6 Polymers 0.000 description 2
- 229920002302 Nylon 6,6 Polymers 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 206010034133 Pathogen resistance Diseases 0.000 description 2
- 229920000297 Rayon Polymers 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 238000002266 amputation Methods 0.000 description 2
- 230000000656 anti-yeast Effects 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- XTVVROIMIGLXTD-UHFFFAOYSA-N copper(II) nitrate Chemical compound [Cu+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O XTVVROIMIGLXTD-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 238000007772 electroless plating Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229910052732 germanium Inorganic materials 0.000 description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 229920001600 hydrophobic polymer Polymers 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 238000009987 spinning Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000589291 Acinetobacter Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 206010056340 Diabetic ulcer Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229920000433 Lyocell Polymers 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- 201000006449 West Nile encephalitis Diseases 0.000 description 1
- 206010057293 West Nile viral infection Diseases 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229920006221 acetate fiber Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
- 230000001668 ameliorated effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000009960 carding Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
- ZURAKLKIKYCUJU-UHFFFAOYSA-N copper;azane Chemical compound N.[Cu+2] ZURAKLKIKYCUJU-UHFFFAOYSA-N 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229940112669 cuprous oxide Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- XWVQUJDBOICHGH-UHFFFAOYSA-N dioctyl nonanedioate Chemical compound CCCCCCCCOC(=O)CCCCCCCC(=O)OCCCCCCCC XWVQUJDBOICHGH-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000010954 inorganic particle Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 229940100890 silver compound Drugs 0.000 description 1
- 150000003379 silver compounds Chemical class 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Substances [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Definitions
- the present invention relates to a method for treating sores, cold sores, cutaneous openings, ulcerations, abrasions, lesions, burns and skin conditions, and to the use of materials incorporating water-insoluble copper compounds for the treatment of sores, cold sores, cutaneous openings, ulcerations, lesions, abrasions, burns and skin conditions.
- the present invention relates to a method for treating sores, cold sores, cutaneous openings, ulcerations, lesions, abrasions, burns and skin conditions comprising applying thereto a wound treating material incorporating water-insoluble copper compounds which release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid.
- the invention also relates to the use of water-insoluble copper compounds which release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid for the manufacture of a material such as a fabric or an extruded film, filament or sheath to be brought in contact with a body surface having sores, abrasions, ulcerations, lesions, cutaneous openings, burns and skin conditions for the treatment and healing thereof.
- a material such as a fabric or an extruded film, filament or sheath to be brought in contact with a body surface having sores, abrasions, ulcerations, lesions, cutaneous openings, burns and skin conditions for the treatment and healing thereof.
- the sheath or extruded film can be of the new types of a monolithic layer with moisture removal properties or micro pores.
- the present invention relates to the use of a polymeric film having microscopic water insoluble particles of ionic copper oxides in powdered form, embedded directly therein with a portion of said particles being exposed and protruding from surfaces thereof, which particles release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid for the manufacture of a bandage for the treatment of sores, cold sores, cutaneous openings, ulcerations, lesions, abrasions , burns and skin conditions.
- the present invention relates to the use of fibers incorporating water-insoluble copper compounds which release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid for the manufacture of a bandage for the treatment of sores, cold sores, cutaneous openings, ulcerations, lesions, abrasions , burns and skin conditions.
- said fibers are polymeric fibers having said compounds incorporated therein and protruding from the surfaces thereof.
- said fibers are coated with said copper compounds
- said material is formed from a polymeric component selected from the group consisting of a polyamide, a polyester, an acrylic and a polyalkylene, which would also include such materials as polypropylene, polyurethane, polyolefin, polyethylene, and other hydrophilic and hydrophobic polymers said material being in the form of a fiber, a yam, or a sheet
- the materials of the present invention are effective in healing ulcerative sores and/or lesions, such as those caused by diabetes, bed sores, burns, acne sores, herpes sores, and are also effective in the healing of skin conditions associated with bacteria, fungus or virus such as eczema, psoriasis, herpes, etc.
- the term "textile” included fibers, whether natural (for example, cotton, silk, wool, and linen) or synthetic yarns spun from those fibers, and woven, knit, and non-woven fabrics made of those yarns.
- the scope of said invention included all natural fibers; and all synthetic fibers used in textile applications, including but not limited to synthetic cellulosic fibers (i.e., regenerated cellulose fibers such as rayon, and cellulose derivative fibers such as acetate fibers), regenerated protein fibers, acrylic fibers, polyolefin fibers, polyurethane fibers, and vinyl fibers, but excluding nylon and polyester fibers, and blends thereof.
- Said invention comprised application to the products of an adaptation of technology used in the electrolyses plating of plastics, particularly printed circuit boards made of plastic, with metals. See, for example, Encyclopedia of Polymer Science and Engineering (Jacqueline I. Kroschwitz, editor), Wiley and Sons, 1987, vol. IX, pp 580-598.
- this process included two steps. The first step was the activation of the textile by precipitating catalytic noble metal nucleation sites on the textile.
- the textile was soaked in a solution of a low- oxidation-state reductant cation, and then soaking the textile in a solution of noble metal cations, preferably a solution of Pd++ cations, most preferably an acidic PdCI 2 solution.
- the low-oxidation-state cation reduces the noble metal cations to the noble metals themselves, while being oxidized to a higher oxidation state.
- the reductant cation is one that is soluble in both the initial low oxidation state and the final high oxidation state, for example Sn++, which is oxidized to Sn++++, or Ti+++, which is oxidized to Ti++++.
- the second step was the reduction, in close proximity to the activated textile, of a metal cation whose reduction was catalyzed by a noble metal.
- the reducing agents used to reduce the cations typically were molecular species, for example, formaldehyde in the case of Cu++. Because the reducing agents were oxidized, the metal cations are termed "oxidant cations" herein.
- the metallized textiles thus produced were characterized in that their metal plating was bonded directly to the textile fibers.
- a textile including fibers selected from the group consisting of natural fibers, synthetic cellulosic fibers, regenerated protein fibers, acrylic fibers, polyolefin fibers, polyurethane fibers, vinyl fibers, and blends thereof; and
- a plating including materials selected from the group consisting of metals and metal oxides; the composition of matter characterized in that said plating is bonded directly to said fibers.
- a textile including fibers selected from the group consisting of natural fibers, synthetic cellulosic fibers, regenerated protein fibers, acrylic fibers, polyolefin fibers, polyurethane fibers, vinyl fibers, and blends thereof; and
- a preferred process for preparing a metallized textile according to said publication comprises the steps of: a) selecting a textile, in a form selected from the group consisting of yarn and fabric, said textile including fibers selected from the group consisting of natural fibers, synthetic cellulosic fibers, regenerated protein fibers, acrylic fibers, polyolefin fibers, polyurethane fibers, vinyl fibers, and blends thereof; b) soaking said textile in a solution containing at least one reductant cationic species having at least two positive oxidation states, said at least one cationic species being in a lower of said at least two positive oxidation states; c) soaking said textile in a solution containing at least one noble metal cationic species, thereby producing an activated textile; and d) reducing at least one oxidant cationic species in a medium in contact with said activated textile, thereby producing a metallized textile.
- An example of said latter use would be the use of a polyethylene core with a polymeric sheath incorporating said water insoluble copper oxide particles to form a yarn with an increased resistance to being cut or ripped while also being both antimicrobial and antiviral and having a multiplicity of uses including in the food preparation industry.
- Said material was described as being made from almost any synthetic polymer, which will allow the introduction of an cationic, copper oxide particles into its liquid slurry state.
- examples of some materials are polyamides (nylon), polyester, acrylic, and polyalkylenes such as polyethylene and polypropylene,
- the copper oxide dust is ground down to fine powder, e.g., a size of between 1 and 10 microns and introduced into the slurry in small quantities, e. g., in an amount of between 0.25 and 10% of the polymer weight, in a master batch as is the accepted practice for manufacturing extruded fibers and films it was found that the subsequent product produced from this slurry exhibited both antimicrobial and antiviral properties.
- the polymer has microscopic water insoluble particles of cationic copper oxide encapsulated therein with a portion of said particles being exposed and protruding from surfaces thereof.
- a slurry is prepared from any polymer, the chief raw material preferably being selected from a polyamide, a polyalkylene, a polyurethane and a polyester. Combinations of more than one of said materials can also be used provided they are compatible or adjusted for compatibility.
- the polymeric raw materials are usually in bead form and can be mono-component, bi-component or multi-component in nature.
- the beads are heated to melting at a temperature which preferably will range from about 120 to 180 0 C.
- a water insoluble powder of cationic copper oxide is added to the slurry and allowed to spread through the heated slurry.
- the particulate size will be preferably between 1 and 10 microns, however can be larger when the film or fiber thickness can accommodate larger particles.
- the liquid slurry is then pushed with pressure through holes in a series of metal plates formed into a circle or other desired shape called a spinneret.
- a spinneret As the slurry is pushed through the fine holes that are close together, they form si ngle fibers or if allowed to contact one another, they form a film or sheath.
- the hot liquid fiber or film is pushed upward with cold air forming a continuous series of fibers or a circular sheet.
- the thickness of the fibers or sheet is controlled by the size of the holes and speed at which the slurry is pushed through the holes and upward by tine cooling air flow.
- antimicrobial compositions comprising] an inorganic particle with a first coating providing antimicrobial properties and a second coating providing a protective function wherein said first coating can be silver or copper or compounds of silver, copper and zinc and preferred are compounds containing silver and copper (II) oxide.
- Said patent is based on the complicated and expensive process involving the coating of the metallic compositions with a secondary protective coating selected from silica, silicates, borosilicates, aluminosilicates, alumina, aluminum phosphate, or mixtures thereof and in fact all the claims are directed to compositions having successive coatings including silica, hydrous alumina and dioctyl azelate.
- the present invention is inter alia directed to the use of a polymeric material, having microscopic water insoluble particles of cationic copper oxide in powder form, which release Cu ++ encapsulated therein with a portion of said particles being exposed and protruding from surfaces thereof, which is neither taught nor suggested by said publication and which has the advantage that the exposed Cu ++ releasing water insoluble particles which protrude from the polymeric material have been proven to be effective in open wound healing.
- EP 427858 there is described an antibacterial composition characterized in that inorganic fine particles are coated with an antibacterial metal and/or antibacterial metal compound and said patent does not teach or suggest a polymer that incorporates microscopic water insoluble particles of cationic copper oxide in powder form, which release Cu ++ encapsulated therein with a portion of said particles being exposed and protruding from surfaces thereof.
- JP-01 046465 there is described a condom releasing sterilizing ions utilizing metals selected from copper, silver, mercury and their alloys whiich metals have a sterilizing and sperm killing effect, wherein the metal is preferably finely powdered copper.
- copper salts such as copper chloride, copper sulfate and copper nitrate are also mentioned, as is known, these are water soluble salts which will dissolve and break down the polymer in which they are introduced.
- cuprous oxide is specifically mentioned, this is a Cu + ionic form, and therefore said patent does not teach or suggest the use of exposed Cu ++ releasing water insoluble particles which protrude from the polymeric material and which have been proven to be effective in open wound healing.
- JP-01 246204 there is described an antimicrobial molded article in which a mixture of a powdery copper compound and organic polysiloxane are dispersed into a thermoplastic molded article for the preparation of cloth, socks, etc.
- Said patent specifically states and teaches that metal ions cannot be introduced by themselves into a polymer molecule and requires the inclusion of organopolysiloxane which is also intended to provide a connecting path for the release of copper ions to the fiber surface.
- said copper compound will be encapsulated and said patent does not teach or suggest the use of exposed Cu ++ releasing water insoluble copper oxide particles that protrude from the polymeric material.
- JP-03 113011 there is described a fiber having good antifungal and hygienic action preferably for producing underwear wherein said synthetic fiber contains copper or a copper compound in combination with germanium or a compound thereof, however, said patent teaches and requires the presence of a major portion of germanium and the copper compounds disclose therein are preferably metallic copper, cuprous iodide which is a monovalent Cu + compound and water soluble copper salts. Thus, said patent does not teach or suggest the use of exposed Cu ++ releasing water insoluble copper oxide particles wh ich protrude from the polymeric material.
- EP 253653 there is described and claimed a polymer containing amorphous aluminosilicate particles comprising an organic polymer and amorphous aluminosilicate solid particles or amorphous aluminosilicate solid particles treated with a coating agent, at least some of said amorphous aluminosilicate solid particles holding metal ions having a bactericidal actions.
- said patent does not teach or suggest the use of exposed Cu ++ releasing water insoluble copper oxide particles, by themselves and in the absence of amorphous aluminosilicate particles, which exposed Cu ++ releasing water insoluble copper oxide particles, protrude from the polymeric material and which have been proven to be effective in open wound healing.
- a second preferred aspect of the present invention relates to the use of a polymeric film having microscopic water insoluble particles of ionic copper oxides in powdered form, embedded directly therein with a portion of said particles being exposed and protruding from surfaces thereof, which particles release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid for the manufacture of a bandage for the treatment of sores, cold sores, cutaneous openings, ulcerations, lesions, abrasions , burns and skin conditions.
- said fibers are polymeric fibers having said compounds incorporated therein and protruding from the surfaces thereof.
- a third preferred aspect of the present invention relates to the use of fibers incorporating water-insoluble copper compounds which release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid for the manufacture of patient attire for hospital and health care facilities, such as nursing homes, senior citizen residences, chronic care faci lities, rehabilitation centers, and hospices to prevent the formation of bed sores and to treat such sores if formed.
- said fibers are preferably polymeric fibers having said compounds incorporated therein and protruding from the surfaces thereof or said fibers are coated with said copper compounds
- a fourth preferred aspect of the present invention relates to the use of a polymeric film having microscopic water insoluble particles of ionic copper oxides in powdered form, embedded directly therein with a portion of said particles being exposed and protruding from surfaces thereof, which particles release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid for the manufacture of a protective sheath for a body limb for the treatment of sores forming thereon.
- said fibers are preferably polymeric fibers having said compounds incorporated therein and protruding from the surfaces thereof or said fibers are coated with said copper compounds.
- a sixth preferred aspect of the present invention relates to the use of fibers incorporating water-insoluble copper compounds which release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid for the manufacture of a dressing for the treatment of sores, cold sores, cutaneous openings, ulcerations, lesions, abrasions , bums and skin conditions.
- An eighth preferred aspect of the present invention relates to the use of fibers incorporating water-insoluble copper compounds which release Cu + ions, Cu + * ions or combinations thereof upon contact with a fluid for the manufacture of underpants for men for treating the outbreak of male genital herpes sores.
- said fibers are preferably polymeric fibers having said compounds incorporated therein and protruding from the surfaces thereof or said fibers are coated with said copper compounds.
- a ninth preferred aspect of the present invention relates to the use of fibers incorporating water-insoluble copper compounds which release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid for the manufacture of bras and nursing pads for nursing mothers for the treatment of nipple sores.
- a tenth preferred aspect of the present invention relates to the use of fibers incorporating water-insoluble copper compounds which release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid for the manufacture of a dressing for the treatment of acne sores.
- said fibers are preferably polymeric fibers having said compounds incorporated therein and protruding from the surfaces thereof or said fibers are coated with said copper compounds.
- said fibers are incorporated into the pad of a padded adhesive bandage.
- An eleventh preferred aspect of the present invention relates to the use of fibers incorporating water-insoluble copper compounds which release Cu + ions, Cu 4+ ions or combinations thereof upon contact with a fluid for the manufacture of a fabricx to be brought in contact with a body surface affected by psoriasis for the treatment: thereof. Also in this eleventh aspect of the present invention said fibers are preferably polymeric fibers having said compounds incorporated therein and protruding from the surfaces thereof or said fibers are coated with said copper compounds.
- a twelfth preferred aspect of the present invention relates to the use of fibers incorporating water-insoluble copper compounds which release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid for the manufacture of a fabric to be brought in contact with a body surface affected by eczema for the treatment thereof.
- said fibers are preferably polymeric fibers having said compounds incorporated therein and protruding from the surfaces thereof or said fibers are coated with said copper compounds.
- a thirteenth preferred aspect of the present invention relates to the use of fibers incorporating water-insoluble copper compounds which release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid, for the manufacture of a fabric to be brought in contact with a body surface having sores, abrasions , bums and skin conditions for the treatment and healing thereof.
- a fourteenth preferred aspect of the present invention relates to the use of fibers incorporating water-insoluble copper compounds which release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid, for the manufacture of a suturing material.
- a fifteenth preferred aspect of the present invention relates to the use of polymeric filament having microscopic water insoluble particles of ionic copper oxides in powdered form, embedded directly therein with a portion of said particles being exposed and protruding from surfaces thereof, which particles release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid for the manufacture of a suturing material.
- a sixteenth preferred aspect of the present invention relates to the use of water-insoluble copper compounds which release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid for the manufacture of a wound- healing fabric to be used in a military uniform or article of inner or outer clothing, said fabric including fibers which upon entry into a wound of a military personnel sustaining a wound while wearing the same, achieves both an anti-bacterial effect and a healing effect on said wound.
- said fibers are preferably polymeric fibers having said compounds incorporated therein and protruding from the surfaces thereof or said fibers are coated with said copper compounds.
- a yet further use of the materials of the present invention is in the formation of the inner lining of a cast.
- a method for treating sores, cold sores, cutaneous openings, ulcerations, lesions , abrasions , burns and skin conditions comprising applying thereto a polymeric material formed from a polymeric component selected from the group consisting of a polyamide, a polyester, an acrylic and a polyalkylene, said material being in the fornn of a fiber, a yarn, a sheath, a filament, or a sheet, and having microscopic water insoluble particles of ionic copper oxides in powdered form, embedded directly therein with a portion of said particles being exposed and protruding from surfaces thereof, which particles release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid.
- a method for preventing the formation of diabetic granulation, lesions and ulcers comprising applying, a material incorporating water-insoluble copper compounds which release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid, to an area to be protected.
- a method for preventing the formation of diabetic granulation, lesions and ulcers comprising applying a polymeric material formed from a polymeric component selected from the group consisting of a polyamide, a polyester, an acrylic and a polyalkylene, said material being in the form of a fiber, a yarn, a sheath, a filament, or a sheet, and having microscopic water insoluble particles of ionic copper oxides in powdered form, embedded directly therein with a portion of said particles being exposed and protruding from surfaces thereof, which particles release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid, to an area to be protected.
- a polymeric material formed from a polymeric component selected from the group consisting of a polyamide, a polyester, an acrylic and a polyalkylene, said material being in the form of a fiber, a yarn, a sheath, a filament, or a sheet, and having microscopic water insoluble particles of ionic copper oxides in powdere
- said material is a fabric having fibers incorporating water-insoluble copper compounds which release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid.
- the present invention relates to a method for treati ng and healing sores, cold sores, cutaneous openings, ulcerations, lesions, abrasions , burns and skin conditions comprising applying to a body surface exhibiting the same, a material incorporating water-insoluble copper compounds which release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid to effect the treatment and healing thereof.
- said sore is an ulcerative sore.
- said sore is a bed sore.
- said sore is an ulcerative sore caused by diabetes.
- said lesion is a vascular lesion.
- said lesion is a mucosal lesion.
- said material is a fabric having fibers incorporating water-insoluble copper compounds which release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid.
- said material is a polymeric film having microscopic water insoluble particles of ionic copper oxides in powdered form, embedded directly therein with a portion of said particles being exposed and protruding from surfaces thereof, which particles release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid.
- said material is a polymeric fiber having microscopic water insoluble particles of ionic copper oxides in powdered form, embedded directly therein with a portion of said particles being exposed and protruding from surfaces thereof, which particles release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid.
- said material is a polymeric filament having microscopic water insoluble particles of ionic copper oxides in powdered form, embedded directly therein with a portion of said particles being exposed and protruding from surfaces thereof, which particles release Cu + ions, Cu + * ions or combinations thereof upon contact with a fluid.
- said material is a polymeric film having microscopic water insoluble particles of ionic copper oxides in powdered form, embedded directly therein with a portion of said particles being exposed and protruding from surfaces thereof, which particles release Cu+ ions, Cu++ ions or combinations thereof upon contact with a fluid wherein said film has the ability to disperse liquid through osmosis.
- a material incorporating water-insoluble copper compounds which release Cu + ions, Cu ++ ions or combinations thereof, upon contact with a fluid can be used in a method for treating and healing sores, cold sores, cutaneous openings, ulcerations, lesions, abrasions , bums and skin conditions to effect the treatment and healing of affected surfaces by applying said material to such an affected body surface, it has now been realized that the present method is effective for treating many conditions.
- the present invention provides a method for treating an outbreak of male genital herpes sores comprising providing underpants having fibers incorporating water-insoluble copper compounds which release Cu "* ions, Cu ++ ions or combinations thereof upon contact with a fluid.
- the present invention also provides a method for treating acne sores comprising applying thereto a fabric having fibers incorporating water-insoluble copper compounds which release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid.
- the present invention provides a method for treating nipple sores on nursing women comprising providing a bra or nursing pad having fibers incorporating water-insoluble copper compounds which release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid.
- the present invention provides a method for treating burns, comprising providing a wound-healing fabric or an extruded wound-healing film, or filament incorporating water-insoluble copper compounds which release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid for application to said burn surface.
- an article of clothing having antibacterial, antifungal, and antiyeast properties comprising at least a panel of a metallized textile, the textile including fibers selected from the group consisting of natural fibers, synthetic cellulosic fibers, regenerated protein fibers, acrylic fibers, polyolefin fibers, polyurethane fibers, vinyl fibers, and blends thereof, and having a plating including an antibacterial, antifungal and antiyeast effective amount of at least one oxidant cationic species of copper.
- said article of clothing was effective against Tinea Pedis, against Candida Albicans, against Thrush and against bacteria causing foot odor, selected from the group of brevubacterium, acinetobacter, micrococcus and combinations thereof, however said patent did not teach or suggest that such an article of clothing were intended for use or would be effective in the treatment of wounds such as sores, cold sores, cutaneous openings, ulcerations, lesions, abrasions , bums and skin conditions.
- WO 01/74166 teaches and claims an antimicrobial and antiviral polymeric material, having microscopic particles which release Cu ++ encapsulated therein and protruding from surfaces thereof but does not teach or suggest the method of the present invention.
- WO 01/81671 teaches and claims a method for combating and preventing nosocomial infections, comprising providing to health care facilities textile fabrics incorporating fibers coated with a cationic form of copper, for use in patient contact and care, wherein said textile fabric is effective for the inactivation of antibiotic resistant strains of bacteria and also does not teach or suggest the use of fibers incorporating water-insoluble copper compounds which release Cu + ions, Cu ++ ions or combinations thereof upon contact with a fluid, for the manufacture of a fabric to be brought in contact with a body surface having sores, cold sores, cutaneous openings, ulcerations, abrasions, lesions , burns and skin conditions for the treatment and healing thereof.
- the cationic species of copper must be exposed to a liquid medium to allow for atomic dispersion into the medium whether said medium is body fluid from an open wound, sore or burn, perspiration which acts as a carrier for said atomic dispersion, or a liquid or surfactant which is added to the fibers or fabric to facilitate the transfer of the ions to the site of the sore, abrasion or bum.
- fibers having ionic copper selected from the group consisting of Cu + and Cu ++ ions are preferably take fibers having ionic copper selected from the group consisting of Cu + and Cu ++ ions and include them in a substrate.
- the fibers In a woven substrate, the fibers would be blended with any other fiber and woven or knit into a substrate. In a non- woven configuration the fibers would be blended to form a thin layer. In both cases, a number of layers could preferably be placed one on top of the other to form a pad.
- the ionic copper used in the method of the present invention is prepared in a manner similar to that described in the earlier specifications referenced above with slight modifications as described hereinafter and is obtained through a redox reaction either on a substrate or alone in the liquid.
- the method of production is an adaptation of technology as used in the electroless plating of plastics, particularly printed circuit boards made of plastic, with metals. See, for example, Encyclopedia of Polymer Science and Engineering (Jacqueline I. Kroschwitz, editor), Wiley and Sons, 1987, vol. IX, pp 580-598. As applied to fibers or fabrics or membranes, this process includes two steps. The first step is the activation of the substrate by precipitating a catalytic noble metal nucleation sites on the substrate surface.
- the substrate is soaked in a solution of a low-oxidation-state reductant cation, and then soaking the substrate in a solution of noble metals cations, preferably a solution of Pd++ cations, most preferable an acidic PdCI 2 solution.
- the low-oxidation-state cation reduces the noble metal cations to the noble metals themselves, while being oxidized to a higher oxidation state.
- the reductant cation is one that is soluble in both the initial low oxidation state and the final high oxidation state, for example Sn++, which is oxidized to Sn++++, or Ti+++. which is oxidized to Ti++++.
- the second step is the reduction, in close proximity to the activated substrate, of a metal cation whose reduction is catalyzed by a noble metal.
- the reducing agents used to reduce the cations typically are molecular species, for example, formaldehyde in the case of Cu++. Because the reducing agents are oxidized, the metal cations are termed "oxidant cations" herein.
- the metallized substrate thus produced is characterized in that their metal plating is bonded directly to the substrate.
- the substrate is allowed to float in a copper solution for reduction as described above, different colors are obtained on each side of the substrate.
- the topside of the substrate is the shiny bright copper (red/yellow) color characteristic of elemental copper - Cu.
- the bottom side of the fabric is a black color, which is characteristic of CuO. Any substrate located under the top substrate also shows a black shade on its upper side.
- This form of electro-less plating process involves the reduction of a cationic form of copper from a copper solution such as copper sulfate or copper nitrate on to a prepared surface on fibers or a substrate.
- the fibers or substrate to be plated must first be soaked in a solution containing at least one reductant cationic species having at least two positive oxidation states, then at least one cationic species being in a lower of the at least two positive oxidation states.
- the fibers or substrate are then soaked in a solution containing at least one noble metal cationic species, thereby producing an activated surface.
- the fibers are then exposed to at least one oxidant cationic species in a medium in contact with the activated surface.
- a reducing agent is then added and the copper reduces itself from the solution on to the surface of the fibers.
- a cationic species of copper must be obtained.
- the effective compounds of copper must contain either a Cu (I) or Cu (II) species or both.
- th ⁇ Pd++ must be applied so that there is equal saturation of all fibers at the same time, e.g. by soaking and squeezing. If a large fiber pack is dropped into the Pd++ solution, the first fibers to hit the solution will absorb more of the Pd++ solution than other parts of the pack, which will upset the cationic copper deposition.
- Wound dressings This can be in the form of a woven gauze or solid thin film.
- the material When in the form of gauze, the material is placed over the wound and taped or held in place as is common practice for the use of a non-treated sterile gauze. If a film is used, than the film is placed over the wound area and taped down around the sides to keep it in place. A film will preferably be used where there is an issue of fibers being caught or stuck to the wound as in burn injuries.
- Bras This can be made knit from either a cellulose or polymeric fiber which can include the water soluble cationic copper oxide particles
- FIG 2a and Figure 2b are photographs of the sole of the foot of said diabetic patient taken before and after treatment according to the present invention as described in example 3 hereinafter
- Figure 4a and Figure 4b are photographs of the sole of the foot of a different diabetic patient taken before and after treatment according to tine present invention as described in example 5 hereinafter.
- Figure 5a and Figure 5b are photographs of a profile of a teenage patient suffering from acne taken before and after treatment according to the present invention as described in example 6 hereinafter.
- Figure 6 is an electron microscope photograph of a polypropylene breathable film which was prepared by introducing 1% water insoluble copper oxide into the master batch before extrusion of the film, to form a film having microscopic water insoluble particles of ionic copper oxides in powdered form, embedded directly therein with a 1160
- Figure 7 is an electron microscope photograph of a polyester fiber prepared by introducing 1 % water insoluble copper oxide into the master batch before extrusion of the fiber, to form fibers having microscopic water insoluble particles of ionic copper oxides in powdered form, embedded directly therein with a portion of said particles being exposed and protruding from surfaces thereof, and showing up as white dots in the electron microscope photograph thereof;
- Example 1 Preparation of fabrics from treated cellulose fibers 1st.
- a cellulose fiber is chosen for the desired end use. Such fibers as Tencel, or acetate, or viscose or raw cotton are among the fibers that can be used.
- Fibers are prepared in a thin mat to assure a deposition of the correct cationic species.
- a chelated copper sulfate solution is prepared using copper sulfate, polyethylglycol, and EDTA. The pH of the solution is controlled by adding sodium hydroxide to the solution. A reductant is added to the copper sulfate solution. While many reductants can be used formaldehyde was chosen as the preferred compound.
- Example 2 Preparation of fabrics or films from treated polymeric materials: A 1.
- a polymeric material is chosen for the desired end use.
- Such fibers as polyester, polypropylene, polyethylene, nylon 66, nylon 6, etc. are among the fibers that can be used.
- the fiber can be formed into either a filament form or short staple form. 60
- a total of 500 grams of a polyamide bi-component compound were prepared by heating the two beaded chemicals in separate baths each at 160 0 C.
- the mixed chemistry was again divided into two separate pots. In one pot, 25 grams of a mixture of CuO and Cu 2 O powder was added yielding a 1 % mixture. In the second pot 6.25 grams of a mixture of CuO and Cu 2 O were added yielding a 0.25% mixture. In both cases, the temperature of 160 °C was maintained. The compounds were stirred until they appeared homogenous in color.
- the two mixtures were run through a spinneret with holes that yielded fibers of between 50 and 70 microns in diameter. Since the Cu++ releasing copper oxide powders were ground to particles of less than 20 microns no obstructions in the spinneret holes were observed. The extruded fibers were air-cooled and spun on to cones.
- the resulting nylon fibers having Cu++ releasing copper oxide incorporated therein can be used in many of the applications of the present invention including in bandages, in socks for diabetics, in gloves or socks for patients suffering from eczema or psoriasis or their hands or feet, etc.
- FIGS. 1a and 2a there are seen the top and sole of a 62 year old white female diabetic patient wherein on the sole of the foot there is seen an ulcerative sore which was 1.5 cm. deep and which had already reached the bone, and therefore this patient was scheduled for amputation of this area of the foot two weeks from the date of September 30, 2004 upon which the photographs of figures 1a and 2a were taken.
- the doctor of this patient who was assisting in clinical trials of the product of the present invention, wrapped the patient's foot with a gauze containing 3% cellulose fibers as prepared according to the method described in US application 10/339886, corresponding to PCT/ILO3/00230 and as described hereinbefore, wherein said treated cellulose fibers are coated with ionic copper selected from tine group consisting of Cu + and Cu ++ ions in that formed on the surface of said fibers are insoluble copper oxide compounds of Cu + and Cu ++'
- FIG 3a there is seen a photograph taken on September 23, 2004 of a lesion on the lateral surface of a foot of a 36 year old white male paraplegic who had this lesion for 6 months as a result of a sore from contact with the limb clamp of his wheelchair.
- the area was wrapped with a polypropylene breathable film which was prepared by introducing 1% water insoluble copper oxide into the master batch before extrusion of the film, to form a film having microscopic water insoluble particles of ionic copper oxides in powdered form, embedded directly therein with a portion of said particles being exposed and protruding from surfaces thereof as seen in figure 6 attached hereto, which partial es release Cu ++ .
- FIG 4a there is seen a photograph of the sole of a 76 year old white male diabetic patient, which photograph was taken on September 28, 20O4, and wherein severe granulation of the skin area is seen.
- FIG 5a there is seen a photograph of the side view of a 16 year old white male suffering from acne which picture was taken on October 10, 2004.
- This patient was instructed to place, each night, adjacent to the affected area, a gauze pad which was made of polyester and in which there were introduced polyester fibers formed with Cu ++ releasing copper oxide powders, which fibers are shown in figure 7 and which fibers have microscopic water insoluble particles of ionic copper oxides in powdered form, embedded directly therein with a portion of said particles being exposed and protruding from surfaces thereof, which particles release Cu ++ to form a gauze pad containing 1 % copper oxide.
- the burn area was covered with a gauze pad according to the present invention which was made of cotton and in which there were introduced cellulosic fibers which were formed with Cu ++ releasing copper oxide powders, which fibers were woven into the gauze to form a final product which was 97% cotton and 3% cationic copper releasing fibers.
- the gauze pad was periodically replaced with fresh pads of the same material for a period of three weeks after which the pad was removed to reveal an area from which the blistered and burnt skin had totally sloughed off leaving a fresh layer of scar-free epidermal tissue, which area one week later was substantially indistinguishable from the surrounding area.
- Example 8 Clinical Testing
- Example 8D Burning Or Itching (23 patients):
- Example 8F Edema (6) Drainage (3V and Odor (5):
- Sample a subset of a population.
- Random sample A subset chosen where each member of the population has a defined, non-zero probability of being chosen.
- p-value the probability that we would obtain the specific sample statistic (or one more extreme) if the null hypothesis (hypothesis of no> change) were true.
- a p-value of less than 0.001 means that the probability of obtaining these results by chance alone is less than 1 in 1000.
- 1 in 20 is considered the "cut-off point.
- Minitab software does not compute p-values to four decimal places, so many of the values obtained here are even smaller.
- a confidence interval contains a range of plausible values for the parameter. We call it a confidence interval, because while unknown, the parameter does exist, and the interval either contains or does not contain the parameter. It is NOT a probability question. For this study, if we assume that no patient would improve in the time frame studied with conventional treatment then so long as the interval does not contain 0, the results are significant, since no plausible value of the parameter is 0. If some other proportion were postulated for improvement, then any interval that did not contain that particular value would be considered significant. In this study, with the above information, all areas reached statistical significance.
- Circle of inference We sample from a population, obtain a result (a statistic), and use that value to infer something about a parameter which is part of a population.
- erythema is characterized by a redness of the skin caused by dilatation and congestion of the capillaries and is often a sign of inflammation or infection, and therefore is a healing issue.
- Scaling is a healing issue when it relates to psoriasis of a microbial nature which is ameliorated by the use of the products of the present invention.
- Vesicular eruptions is an eruption of capillaries that are close to the surface of the skin and is thus also a healing issue.
- Drainage is the removal of fluid or purulent material from a wound or body cavity which is facilitated by the products of the present invention which promote wound healing.
- Edema is an observable swelling in certain parts in the body and most commonly occurs in the feet and legs where it also is referred to as peripheral edema.
- the swelling is the result of the accumulation of excess fluid under the skin in the spaces within the tissues that are outside of the blood vessels and the healing thereof is facilitated by the method and products of the present invention.
- Fissuring is a break in the skin usually where it joins a mucous membrane producing a crack-like sore or ulcer and this is also a healing issue which can be dealt with according to the present invention.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Reproductive Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Obesity (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2587029A CA2587029C (en) | 2004-11-07 | 2005-11-07 | Methods and materials for treating wounds, burns, and skin conditions |
ES05803225T ES2407056T3 (en) | 2004-11-07 | 2005-11-07 | Materials containing copper to treat wounds, burns and other skin diseases |
MX2007005476A MX2007005476A (en) | 2004-11-07 | 2005-11-07 | Copper containing materials for treating wounds, burns and other skin conditions. |
EP05803225A EP1809306B1 (en) | 2004-11-07 | 2005-11-07 | Copper containing materials for treating wounds, burns and other skin conditions |
JP2007539711A JP5275629B2 (en) | 2004-11-07 | 2005-11-07 | Copper-containing material for the treatment of wounds, burns and other skin conditions |
KR1020137033264A KR20140013078A (en) | 2004-11-07 | 2005-11-07 | Copper containing materials for treating wounds, burns and other skin conditions |
NZ555072A NZ555072A (en) | 2004-11-07 | 2005-11-07 | Copper containing materials for treating wounds, burns and other skin conditions |
AU2005302085A AU2005302085B2 (en) | 2004-11-07 | 2005-11-07 | Copper containing materials for treating wounds, burns and other skin conditions |
US11/667,182 US20080311165A1 (en) | 2004-11-07 | 2005-11-07 | Copper Containing Materials for Treating Wounds, Burns and Other Skin Conditions |
KR1020077012748A KR101528918B1 (en) | 2004-11-07 | 2005-11-07 | Copper containing materials for treating wounds, burns and other skin conditions |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL16506404A IL165064A0 (en) | 2004-11-07 | 2004-11-07 | Methods and materials for treating wounds, burns, and skin conditions |
IL165,064 | 2004-11-07 | ||
IL171,807 | 2005-11-07 | ||
IL171807A IL171807A (en) | 2005-11-07 | 2005-11-07 | Materials for treating wounds, burns and skin conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006048879A1 true WO2006048879A1 (en) | 2006-05-11 |
Family
ID=35810079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2005/001160 WO2006048879A1 (en) | 2004-11-07 | 2005-11-07 | Copper containing materials for treating wounds, burns and other skin conditions |
Country Status (11)
Country | Link |
---|---|
US (1) | US20080311165A1 (en) |
EP (1) | EP1809306B1 (en) |
JP (2) | JP5275629B2 (en) |
KR (2) | KR101528918B1 (en) |
CN (1) | CN102441190A (en) |
AU (1) | AU2005302085B2 (en) |
CA (1) | CA2587029C (en) |
ES (1) | ES2407056T3 (en) |
MX (1) | MX2007005476A (en) |
NZ (1) | NZ555072A (en) |
WO (1) | WO2006048879A1 (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008029387A1 (en) * | 2006-09-10 | 2008-03-13 | The Cupron Corporation | Multi-layered material |
WO2008117277A2 (en) * | 2007-03-28 | 2008-10-02 | The Cupron Corporation | Antimicrobial, antifungal and antiviral rayon fibers |
WO2011051948A2 (en) | 2009-11-02 | 2011-05-05 | Cupron Scientific Ltd | Hair care compositions and materials |
WO2013026912A1 (en) | 2011-08-23 | 2013-02-28 | Birgit Riesinger | Hygienic or personal care article having a content of copper or copper ions |
EP2572653A1 (en) * | 2011-09-20 | 2013-03-27 | implantcast GmbH | Wound clamp |
US8530720B2 (en) | 2011-07-29 | 2013-09-10 | Aluminaid International Ag | Thermally conductive, metal-based bandages to aid in medical healing and methods of use |
US8734421B2 (en) | 2003-06-30 | 2014-05-27 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating pores on the skin with electricity |
US9044397B2 (en) | 2009-03-27 | 2015-06-02 | Ethicon, Inc. | Medical devices with galvanic particulates |
WO2015084231A1 (en) * | 2013-12-02 | 2015-06-11 | Jaban Ab | Wound healing material comprising copper |
EP2993252A4 (en) * | 2013-02-01 | 2016-07-20 | Compañia Minera San Geronimo | Impregnatable matrix of plant, animal or synthetic origin or mixtures of same, containing a uniformly distributed antimicrobial compound, method for impregnating said matrix with a compound, and use thereof in the production of antimicrobial elements |
US9403041B2 (en) | 2004-11-09 | 2016-08-02 | Cupron Inc. | Methods and materials for skin care |
US9439437B2 (en) | 2000-04-05 | 2016-09-13 | Cupron Inc. | Antimicrobial and antiviral polymeric materials |
US10998467B2 (en) | 2019-09-25 | 2021-05-04 | Nano Sono Cooperation Ltd. | Compositions of metal oxide semiconductor nanomaterials and hemostatic polymers |
US10995011B2 (en) | 2019-01-17 | 2021-05-04 | Nano Sono Cooperation Ltd. | Compositions of metal oxide semiconductor nanomaterials |
US11464232B2 (en) | 2014-02-19 | 2022-10-11 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
US11470847B2 (en) | 2014-02-19 | 2022-10-18 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
US11730824B2 (en) | 2019-01-17 | 2023-08-22 | Nsc Nano Sono Cooperation Ltd. | Drug-releasing compositions of metal oxide semiconductor nanomaterials and hemostatic polymers |
US11820672B2 (en) | 2019-01-17 | 2023-11-21 | Nano Sono Cooperation Ltd. | Processes for preparing metal oxide semiconductor nanomaterials |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009120365A2 (en) | 2008-03-27 | 2009-10-01 | Agigma, Inc. | Methods and compositions for the delivery of agents |
CA2776363C (en) | 2009-10-02 | 2019-02-19 | Nbc Meshtec, Inc. | Virus inactivating sheet |
EP2496239B1 (en) | 2009-11-06 | 2018-01-03 | Care Fusion 2200, Inc. | Copper salts of ion exchange materials for use in the treatment and prevention of infections |
WO2012046229A2 (en) * | 2010-10-04 | 2012-04-12 | Cupron Scientific Ltd | Cosmetic skin care compositions |
JP6002757B2 (en) * | 2011-05-24 | 2016-10-05 | アジエニック,インコーポレイテッド | Composition and method of antibacterial metal nanoparticles |
US9155310B2 (en) | 2011-05-24 | 2015-10-13 | Agienic, Inc. | Antimicrobial compositions for use in products for petroleum extraction, personal care, wound care and other applications |
US20130085434A1 (en) * | 2011-09-30 | 2013-04-04 | Tyco Healthcare Group Lp | Wound Dressing And Related Methods Therefor |
JP5812488B2 (en) | 2011-10-12 | 2015-11-11 | 昭和電工株式会社 | Antibacterial antiviral composition and method for producing the same |
US11007143B2 (en) | 2013-03-15 | 2021-05-18 | Cda Research Group, Inc. | Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body |
US11000545B2 (en) | 2013-03-15 | 2021-05-11 | Cda Research Group, Inc. | Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza |
US10398733B2 (en) | 2013-03-15 | 2019-09-03 | Cda Research Group, Inc. | Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body |
US11318089B2 (en) | 2013-03-15 | 2022-05-03 | Cda Research Group, Inc. | Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body |
US11083750B2 (en) | 2013-03-15 | 2021-08-10 | Cda Research Group, Inc. | Methods of treatment using topical copper ion formulations |
US11039621B2 (en) | 2014-02-19 | 2021-06-22 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
CN103880868B (en) * | 2014-03-31 | 2016-04-27 | 许东东 | A kind of organic copper antibacterial nylon silk, organic copper complex preparation method |
US9579606B2 (en) * | 2014-07-23 | 2017-02-28 | Air Liquide Advanced Technologies U.S. Llc | Gas separation membrane module with improved gas seal |
CN107207771B (en) | 2015-02-08 | 2019-12-06 | 阿尔贾曼技术有限公司 | Antimicrobial materials comprising synergistic combinations of metal oxides |
US11224227B2 (en) | 2015-02-08 | 2022-01-18 | Argaman Technologies Ltd. | Antimicrobial material comprising synergistic combinations of metal oxides |
TWI754608B (en) * | 2015-02-08 | 2022-02-11 | 以色列商阿爾賈曼技術有限公司 | Skin-regenerating material comprising synergistic combination of metal oxides |
WO2016168993A1 (en) | 2015-04-22 | 2016-10-27 | Innolife Co., Ltd. | Methods of tissue repair and regeneration |
JP6815006B2 (en) * | 2016-11-01 | 2021-01-20 | 株式会社桃谷順天館 | Acne strain selective antibacterial agent |
WO2018104937A1 (en) * | 2016-12-06 | 2018-06-14 | Sami Shamoon College Of Engineering (R.A.) | Topical antimicrobial formulations containing monovalent copper ions and systems for generating monovalent copper ions |
CA3054201A1 (en) * | 2017-02-21 | 2018-08-30 | Fine Cotton Factory Inc. | Articles for treating concussion and other disorders |
CN113973842A (en) * | 2017-10-12 | 2022-01-28 | 揖斐电株式会社 | Antimicrobial compositions |
EA202191494A1 (en) * | 2018-12-10 | 2021-09-20 | Медку Текнолоджис Лтд. | METHOD FOR PREVENTING AND REDUCING SKIN STASIS USING COMPOSITIONS AND MATERIALS CONTAINING COPPER COMPOUNDS |
US11193184B2 (en) | 2019-02-22 | 2021-12-07 | Cda Research Group, Inc. | System for use in producing a metal ion suspension and process of using same |
JP7229215B2 (en) * | 2020-10-21 | 2023-02-27 | イビデン株式会社 | antiviral component |
JP7229216B2 (en) * | 2020-10-21 | 2023-02-27 | イビデン株式会社 | antiviral component |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2092006A (en) * | 1981-02-04 | 1982-08-11 | Landstingens Inkopscentral | Germicidal dressing |
WO2000075415A1 (en) * | 1999-06-07 | 2000-12-14 | The Cupron Corporation | An article of clothing having antibacterial, antifungal, and antiyeast properties |
WO2001074166A1 (en) * | 2000-04-05 | 2001-10-11 | The Cupron Corporation | Antimicrobial and antiviral polymeric materials |
WO2003009877A1 (en) * | 2001-07-24 | 2003-02-06 | Advanced Biotechnologies International | Topical pharmaceutical formulation |
WO2003018495A1 (en) * | 2001-08-22 | 2003-03-06 | Schott Glas | Water-insoluble, antimicrobial silicate glass and use thereof |
WO2003088983A1 (en) * | 2002-04-17 | 2003-10-30 | Conve Ltd | Use of topical compositions for the control of microbial diseases of the nail |
WO2004073758A1 (en) * | 2003-02-21 | 2004-09-02 | The Cupron Corporation | Disposable feminine hygiene products |
WO2004073756A1 (en) * | 2003-02-21 | 2004-09-02 | The Cupron Corporation | Disposable diaper for combating diaper rash |
Family Cites Families (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1947451A (en) * | 1932-10-03 | 1934-02-20 | Crown Willamette Paper Company | Copperized paper |
US2395015A (en) * | 1940-08-27 | 1946-02-19 | Rayonier Inc | Cuprammonium process |
GB1021537A (en) * | 1963-03-07 | 1966-03-02 | Teijin Ltd | Method of producing viscose rayon staple and a spinning apparatus for use in the method |
US3300336A (en) * | 1963-09-09 | 1967-01-24 | Scient Chemicals Inc | Metal containing compositions, processes and products |
US3385915A (en) * | 1966-09-02 | 1968-05-28 | Union Carbide Corp | Process for producing metal oxide fibers, textiles and shapes |
NO117649B (en) * | 1964-11-02 | 1969-09-08 | Tachikawa Res Inst | |
US3308488A (en) * | 1965-05-03 | 1967-03-14 | Richard J Schoonman | Bacteriostatic drawsheet |
DE1494725A1 (en) * | 1965-08-19 | 1969-09-25 | Phrix Werke Ag | Method and device for the production of threads and fibers from regenerated cellulose |
IE31637L (en) * | 1967-11-06 | 1968-05-15 | Chimiotex | Regenerated cellulose filaments |
US3860529A (en) * | 1968-01-24 | 1975-01-14 | Union Carbide Corp | Stabilized tetragonal zirconia fibers and textiles |
US3875141A (en) * | 1968-02-16 | 1975-04-01 | Chimiotex | Regenerated cellulose filaments |
US3663182A (en) * | 1968-03-29 | 1972-05-16 | Union Carbide Corp | Metal oxide fabrics |
US3720743A (en) * | 1970-10-20 | 1973-03-13 | Itt | Process for producing high performance crimped rayon staple fiber |
US3716615A (en) * | 1971-08-24 | 1973-02-13 | Us Interior | Process for the production of cuprous oxide |
US3821163A (en) * | 1971-08-30 | 1974-06-28 | Ciba Geigy Corp | Metal complexes of n,n'-dialkylesters of ethylenedinitrilo-tetraacetic acid:stabilizers for polymers |
US4072784A (en) * | 1974-08-28 | 1978-02-07 | The United States Of America As Represented By The Secretary Of Agriculture | Fixation of multivalent metal salts of carboxyl-containing vinyl monomers on fibrous substrates |
JPS5238013A (en) * | 1975-09-20 | 1977-03-24 | Hitachi Cable Ltd | Sanitary treatment of materials used in contact with the skin |
US4103450A (en) * | 1975-12-29 | 1978-08-01 | Minnesota Mining And Manufacturing Company | Insecticidal device |
US4219602A (en) * | 1976-04-29 | 1980-08-26 | Herculite Protective Fabrics Corporation | Electrically conductive/antistatic sheeting |
JPS53748A (en) * | 1976-06-23 | 1978-01-06 | Akira Yamauchi | Foot wear member containing metallic fine powder for vesicular eczema |
US4115422A (en) * | 1977-04-12 | 1978-09-19 | The United States Of America As Represented By The Secretary Of Agriculture | Antibacterial textile finishes utilizing zirconyl acetate complexes of inorganic peroxides |
DE2743768C3 (en) * | 1977-09-29 | 1980-11-13 | Bayer Ag, 5090 Leverkusen | Metallized textile material |
DE2852375A1 (en) * | 1978-12-04 | 1980-06-26 | Dynamit Nobel Ag | INSULATING BODY WITH METAL PARTICLES DISTRIBUTED IN THE RESIN |
DE2910460A1 (en) * | 1979-03-16 | 1980-09-25 | Bayer Ag | METHOD FOR PARTIAL METALIZING OF TEXTILES |
JPS55137210A (en) * | 1979-04-05 | 1980-10-25 | Mitsubishi Rayon Co Ltd | Antimicrobial fiber |
US4291086A (en) * | 1979-05-17 | 1981-09-22 | Auten Jerry P | Coating system for roofs, swimming pools and the like |
JPS56125055A (en) * | 1980-02-27 | 1981-10-01 | Hideaki Uragami | Medical treatment member |
JPS577452A (en) * | 1980-06-18 | 1982-01-14 | Mitsui Toatsu Chem Inc | Purification of aqueous acrylamide |
SE432194B (en) * | 1980-09-17 | 1984-03-26 | Landstingens Inkopscentral | MOISTURIZING AND BACTERIODIC ABSORPTION BODY FOR URINE AND FAECES, WHICH INCLUDE A WATER-SOLUBLE COPPER SALT |
US4390585A (en) * | 1982-05-05 | 1983-06-28 | Bond Cote Of Virginia, Inc. | Durable flexible membrane and method of making same |
JPS5937956A (en) * | 1982-08-24 | 1984-03-01 | カネボウ株式会社 | Particle filled fiber structure |
FR2534243B1 (en) * | 1982-10-11 | 1986-02-14 | Saint Gobain Vitrage | PROCESS FOR THE TRANSPORT OF GLASS SHEETS CARRIED TO THEIR DEFORMATION TEMPERATURE, ITS APPLICATION TO BOMBING AND DEVICE FOR ITS IMPLEMENTATION |
US4428773A (en) * | 1982-12-30 | 1984-01-31 | Western Electric Company, Inc. | Process for treating spent fluids to recover copper and copper oxide |
US4556560A (en) * | 1983-01-24 | 1985-12-03 | The Procter & Gamble Company | Methods for the treatment and prophylaxis of diaper rash and diaper dermatitis |
DE3408130A1 (en) * | 1984-03-06 | 1985-09-12 | Henkel KGaA, 4000 Düsseldorf | SANITARY HYGIENE AGENTS |
DE3430611A1 (en) * | 1984-08-20 | 1986-02-20 | Werner & Mertz Gmbh, 6500 Mainz | AGENTS FOR THE KILLING OF HOUSE DUST MITES AND THE USE THEREOF |
JPS62106778A (en) * | 1985-11-05 | 1987-05-18 | 天昇電気工業株式会社 | Gas mask |
JPS62191574A (en) * | 1986-02-15 | 1987-08-21 | スミクロス工業株式会社 | Drawing cloth |
JPS62210098A (en) * | 1986-03-07 | 1987-09-16 | Kyoritsu Glass Kk | Glass water treating agent |
US5316846A (en) * | 1986-03-24 | 1994-05-31 | Ensci, Inc. | Coated substrates |
US5306522A (en) * | 1986-03-24 | 1994-04-26 | Ensci, Inc. | Process for coating a substrate with zinc oxide and uses for coated substrates |
US4999240A (en) * | 1986-07-21 | 1991-03-12 | Brotz Gregory R | Metalized fiber/member structures and methods of producing same |
US5024875A (en) * | 1986-09-09 | 1991-06-18 | Burlington Industries, Inc. | Antimicrobial microporous coating |
US5017420A (en) * | 1986-10-23 | 1991-05-21 | Hoechst Celanese Corp. | Process for preparing electrically conductive shaped articles from polybenzimidazoles |
US4900618A (en) * | 1986-11-07 | 1990-02-13 | Monsanto Company | Oxidation-resistant metal coatings |
JPS63179934A (en) * | 1987-01-21 | 1988-07-23 | Daicel Chem Ind Ltd | Deodorant and mildew-proofing resin sheet |
US5009946A (en) * | 1987-03-03 | 1991-04-23 | Kuraray Company Limited | Composite sheet for automotive use |
US4983573A (en) * | 1987-06-09 | 1991-01-08 | E. I. Du Pont De Nemours And Company | Process for making 90° K. superconductors by impregnating cellulosic article with precursor solution |
FR2619503A1 (en) * | 1987-08-20 | 1989-02-24 | Hutchinson | APPLICATION OF MICROCAPSULES TO THE MANUFACTURE OF A PROPHYLACTIC DEVICE IN ELASTOMERIC MATERIAL, SUCH AS A PRESERVATIVE OR ANALOGUE, AND METHOD OF MANUFACTURING THE SAME |
US5399425A (en) * | 1988-07-07 | 1995-03-21 | E. I. Du Pont De Nemours And Company | Metallized polymers |
CA2074499A1 (en) * | 1989-12-29 | 1994-01-24 | Edwin D. Rosenberger | Germicidal dental floss and method for fabrication |
JP2926717B2 (en) * | 1988-09-22 | 1999-07-28 | 三菱瓦斯化学株式会社 | Sheet oxygen absorber |
US5200256A (en) * | 1989-01-23 | 1993-04-06 | Dunbar C R | Composite lightweight bullet proof panel for use on vessels, aircraft and the like |
US5089205A (en) * | 1989-09-25 | 1992-02-18 | Becton, Dickinson And Company | Process for producing medical devices having antimicrobial properties |
WO1992003390A1 (en) * | 1990-08-28 | 1992-03-05 | Union Carbide Industrial Gases Technology Corporation | Fabrication of superconducting metal-oxide textiles |
JP3169621B2 (en) * | 1991-01-29 | 2001-05-28 | 株式会社タカミツ | Antimicrobial external preparation |
US5217626A (en) * | 1991-05-28 | 1993-06-08 | Research Corporation Technologies, Inc. | Water disinfection system and method |
US5180585A (en) * | 1991-08-09 | 1993-01-19 | E. I. Du Pont De Nemours And Company | Antimicrobial compositions, process for preparing the same and use |
US5869412A (en) * | 1991-08-22 | 1999-02-09 | Minnesota Mining & Manufacturing Co. | Metal fibermat/polymer composite |
JP3452923B2 (en) * | 1991-11-27 | 2003-10-06 | カルゴン カーボン コーポレーション | Universal impregnated activated carbon for respirator without chromium to adsorb toxic gases and / or vapors |
JPH063322U (en) * | 1992-04-07 | 1994-01-18 | 弘 川又 | Antibacterial copper metal for remediation of athlete's foot symptoms |
US5414913A (en) * | 1992-05-12 | 1995-05-16 | Wetmore Associates | Ultraviolet protective fabric |
US6247221B1 (en) * | 1992-09-17 | 2001-06-19 | Coors Tek, Inc. | Method for sealing and/or joining an end of a ceramic filter |
US5411795A (en) * | 1992-10-14 | 1995-05-02 | Monsanto Company | Electroless deposition of metal employing thermally stable carrier polymers |
JP3201023B2 (en) * | 1992-11-17 | 2001-08-20 | 東亞合成株式会社 | Manufacturing method of antibacterial synthetic fiber |
US5316837A (en) * | 1993-03-09 | 1994-05-31 | Kimberly-Clark Corporation | Stretchable metallized nonwoven web of non-elastomeric thermoplastic polymer fibers and process to make the same |
US5391432A (en) * | 1993-04-28 | 1995-02-21 | Mitchnick; Mark | Antistatic fibers |
JPH07138155A (en) * | 1993-11-12 | 1995-05-30 | Otsuka Pharmaceut Co Ltd | Antimicrobial agent |
US5549972A (en) * | 1994-02-10 | 1996-08-27 | E. I. Du Pont De Nemours & Company | Silver-plated fibers of poly(p-phenylene terephthalamide) and a process for making them |
US5881353A (en) * | 1994-03-31 | 1999-03-09 | Hitachi Chemical Company, Ltd. | Method for producing porous bodies |
US5547610A (en) * | 1994-05-03 | 1996-08-20 | Forbo Industries, Inc. | Conductive polymeric adhesive for flooring containing silver-coated non-conductive fiber cores |
IL113534A0 (en) * | 1995-04-28 | 1995-07-31 | Shenkar College Textile Tech | Microbistatic and deodorizing of cellulose fibers |
JP2929269B2 (en) * | 1995-11-21 | 1999-08-03 | 生命エネルギー工業株式会社 | Bedding with electret function |
DE69736510T2 (en) * | 1996-05-10 | 2007-04-05 | Toyo Boseki K.K. | ANTIMICROBIAL COMPOSITION AND ANTIMICROBIAL LAMINATE |
US5939340A (en) * | 1996-08-09 | 1999-08-17 | Mtc Medical Fibers Ltd | Acaricidal fabric |
US5871816A (en) * | 1996-08-09 | 1999-02-16 | Mtc Ltd. | Metallized textile |
US5904854A (en) * | 1997-01-31 | 1999-05-18 | Electrophor, Inc. | Method for purifying water |
US6067444A (en) * | 1997-06-13 | 2000-05-23 | Motorola, Inc. | Method and apparatus for duplicate message processing in a selective call device |
US6036839A (en) * | 1998-02-04 | 2000-03-14 | Electrocopper Products Limited | Low density high surface area copper powder and electrodeposition process for making same |
US6446814B1 (en) * | 1999-04-22 | 2002-09-10 | Joseph A. King | Method of making a dual filter |
US6383273B1 (en) * | 1999-08-12 | 2002-05-07 | Apyron Technologies, Incorporated | Compositions containing a biocidal compound or an adsorbent and/or catalyst compound and methods of making and using therefor |
JP4118563B2 (en) * | 1999-08-13 | 2008-07-16 | ビーエーエスエフ ソシエタス・ヨーロピア | Colorant preparation |
US6627676B1 (en) * | 1999-08-27 | 2003-09-30 | Richard George | Antimicrobial biocidic fiber-plastic composite and method of making same |
IT1310042B1 (en) * | 1999-11-26 | 2002-02-05 | Pier Luigi Delvigo | FILTER WITHOUT DEAD SPACE |
US20050150514A1 (en) * | 2000-04-05 | 2005-07-14 | The Cupron Corporation | Device for cleaning tooth and gum surfaces |
BR0110289A (en) * | 2000-04-26 | 2003-02-18 | Johnson Diversey Inc | Method for determining amylase concentrations |
US6369289B1 (en) * | 2000-07-07 | 2002-04-09 | Tyco Healthcare Group Lp | Method and manufacture of a wound dressing for covering an open wound |
KR100496776B1 (en) * | 2001-06-21 | 2005-06-22 | 삼성토탈 주식회사 | Catalyst for polymerization and copolymerization of ethylene |
US6681765B2 (en) * | 2001-12-18 | 2004-01-27 | Sheree H. Wen | Antiviral and antibacterial respirator mask |
US20030152610A1 (en) * | 2002-01-28 | 2003-08-14 | David Rolf | Cosmetic patch |
US6861002B2 (en) * | 2002-04-17 | 2005-03-01 | Watervisions International, Inc. | Reactive compositions for fluid treatment |
JP2004161642A (en) * | 2002-11-12 | 2004-06-10 | Tadashi Inoue | Skin medicine, such as plaster, ointment or spray, containing inorganic antimicrobial agent |
US20040105894A1 (en) * | 2002-11-29 | 2004-06-03 | Gupta Shyam K. | Trace Metals synergized copper nucleotides and copper glycosides for anti-aging and antiviral compositions |
US20040167483A1 (en) * | 2003-02-21 | 2004-08-26 | The Cupron Corporation C/O Law Offices Of Mr. Sylavin Jakabovics | Disposable diaper for combating diaper rash |
US20040180093A1 (en) * | 2003-03-12 | 2004-09-16 | 3M Innovative Properties Company | Polymer compositions with bioactive agent, medical articles, and methods |
US7364756B2 (en) * | 2003-08-28 | 2008-04-29 | The Cuprin Corporation | Anti-virus hydrophilic polymeric material |
IL157625A0 (en) * | 2003-08-28 | 2004-03-28 | Cupron Corp | Anti-virus hydrophilic polymeric material |
AU2005303369B2 (en) * | 2004-11-09 | 2011-08-04 | Cupron Inc. | Methods and materials for skin care |
US20080193496A1 (en) * | 2005-03-21 | 2008-08-14 | The Cupron Corporation | Antimicrobial And Antiviral Polymeric Master Batch, Processes For Producing Polymeric Material Therefrom And Products Produced Therefrom |
-
2005
- 2005-11-07 KR KR1020077012748A patent/KR101528918B1/en active IP Right Grant
- 2005-11-07 MX MX2007005476A patent/MX2007005476A/en active IP Right Grant
- 2005-11-07 US US11/667,182 patent/US20080311165A1/en not_active Abandoned
- 2005-11-07 KR KR1020137033264A patent/KR20140013078A/en active IP Right Grant
- 2005-11-07 EP EP05803225A patent/EP1809306B1/en active Active
- 2005-11-07 ES ES05803225T patent/ES2407056T3/en active Active
- 2005-11-07 JP JP2007539711A patent/JP5275629B2/en active Active
- 2005-11-07 AU AU2005302085A patent/AU2005302085B2/en active Active
- 2005-11-07 WO PCT/IL2005/001160 patent/WO2006048879A1/en active Application Filing
- 2005-11-07 CN CN2011104151026A patent/CN102441190A/en active Pending
- 2005-11-07 NZ NZ555072A patent/NZ555072A/en unknown
- 2005-11-07 CA CA2587029A patent/CA2587029C/en active Active
-
2012
- 2012-12-07 JP JP2012268772A patent/JP2013081792A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2092006A (en) * | 1981-02-04 | 1982-08-11 | Landstingens Inkopscentral | Germicidal dressing |
WO2000075415A1 (en) * | 1999-06-07 | 2000-12-14 | The Cupron Corporation | An article of clothing having antibacterial, antifungal, and antiyeast properties |
WO2001074166A1 (en) * | 2000-04-05 | 2001-10-11 | The Cupron Corporation | Antimicrobial and antiviral polymeric materials |
WO2003009877A1 (en) * | 2001-07-24 | 2003-02-06 | Advanced Biotechnologies International | Topical pharmaceutical formulation |
WO2003018495A1 (en) * | 2001-08-22 | 2003-03-06 | Schott Glas | Water-insoluble, antimicrobial silicate glass and use thereof |
WO2003088983A1 (en) * | 2002-04-17 | 2003-10-30 | Conve Ltd | Use of topical compositions for the control of microbial diseases of the nail |
WO2004073758A1 (en) * | 2003-02-21 | 2004-09-02 | The Cupron Corporation | Disposable feminine hygiene products |
WO2004073756A1 (en) * | 2003-02-21 | 2004-09-02 | The Cupron Corporation | Disposable diaper for combating diaper rash |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9439437B2 (en) | 2000-04-05 | 2016-09-13 | Cupron Inc. | Antimicrobial and antiviral polymeric materials |
US8734421B2 (en) | 2003-06-30 | 2014-05-27 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating pores on the skin with electricity |
US9931283B2 (en) | 2004-11-09 | 2018-04-03 | Cupron Inc. | Methods and materials for skin care |
US9403041B2 (en) | 2004-11-09 | 2016-08-02 | Cupron Inc. | Methods and materials for skin care |
WO2008029387A1 (en) * | 2006-09-10 | 2008-03-13 | The Cupron Corporation | Multi-layered material |
US8741197B2 (en) | 2007-03-28 | 2014-06-03 | Cupron Inc. | Antimicrobial, antifungal and antiviral rayon fibers |
EP1978138A2 (en) * | 2007-03-28 | 2008-10-08 | The Cupron Corporation | Anitimicrobial, antifungal and antiviral rayon fibers |
JP2010522833A (en) * | 2007-03-28 | 2010-07-08 | ザ カプロン コーポレイション | Antibacterial, antifungal and antiviral rayon fibers |
WO2008117277A3 (en) * | 2007-03-28 | 2009-03-12 | Cupron Corp | Antimicrobial, antifungal and antiviral rayon fibers |
WO2008117277A2 (en) * | 2007-03-28 | 2008-10-02 | The Cupron Corporation | Antimicrobial, antifungal and antiviral rayon fibers |
EP1978138A3 (en) * | 2007-03-28 | 2009-03-04 | The Cupron Corporation | Anitimicrobial, antifungal and antiviral rayon fibers |
US9044397B2 (en) | 2009-03-27 | 2015-06-02 | Ethicon, Inc. | Medical devices with galvanic particulates |
WO2011051948A3 (en) * | 2009-11-02 | 2012-07-05 | Cupron Scientific Ltd | Hair care compositions and materials |
WO2011051948A2 (en) | 2009-11-02 | 2011-05-05 | Cupron Scientific Ltd | Hair care compositions and materials |
US8530720B2 (en) | 2011-07-29 | 2013-09-10 | Aluminaid International Ag | Thermally conductive, metal-based bandages to aid in medical healing and methods of use |
US9271875B2 (en) | 2011-07-29 | 2016-03-01 | Harrisburg (B.V.I.) Limited | Thermally conductive, metal-based bandages to aid in medical healing and methods of use |
WO2013026912A1 (en) | 2011-08-23 | 2013-02-28 | Birgit Riesinger | Hygienic or personal care article having a content of copper or copper ions |
EP2572653A1 (en) * | 2011-09-20 | 2013-03-27 | implantcast GmbH | Wound clamp |
EP2993252A4 (en) * | 2013-02-01 | 2016-07-20 | Compañia Minera San Geronimo | Impregnatable matrix of plant, animal or synthetic origin or mixtures of same, containing a uniformly distributed antimicrobial compound, method for impregnating said matrix with a compound, and use thereof in the production of antimicrobial elements |
WO2015084231A1 (en) * | 2013-12-02 | 2015-06-11 | Jaban Ab | Wound healing material comprising copper |
US11464232B2 (en) | 2014-02-19 | 2022-10-11 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
US11470847B2 (en) | 2014-02-19 | 2022-10-18 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
US11751570B2 (en) | 2014-02-19 | 2023-09-12 | Corning Incorporated | Aluminosilicate glass with phosphorus and potassium |
US10995011B2 (en) | 2019-01-17 | 2021-05-04 | Nano Sono Cooperation Ltd. | Compositions of metal oxide semiconductor nanomaterials |
US11730824B2 (en) | 2019-01-17 | 2023-08-22 | Nsc Nano Sono Cooperation Ltd. | Drug-releasing compositions of metal oxide semiconductor nanomaterials and hemostatic polymers |
US11820672B2 (en) | 2019-01-17 | 2023-11-21 | Nano Sono Cooperation Ltd. | Processes for preparing metal oxide semiconductor nanomaterials |
US10998467B2 (en) | 2019-09-25 | 2021-05-04 | Nano Sono Cooperation Ltd. | Compositions of metal oxide semiconductor nanomaterials and hemostatic polymers |
Also Published As
Publication number | Publication date |
---|---|
KR20140013078A (en) | 2014-02-04 |
CA2587029A1 (en) | 2006-05-11 |
NZ555072A (en) | 2010-09-30 |
JP2008518712A (en) | 2008-06-05 |
AU2005302085B2 (en) | 2011-03-17 |
AU2005302085A1 (en) | 2006-05-11 |
JP2013081792A (en) | 2013-05-09 |
KR101528918B1 (en) | 2015-06-15 |
CN102441190A (en) | 2012-05-09 |
US20080311165A1 (en) | 2008-12-18 |
JP5275629B2 (en) | 2013-08-28 |
EP1809306B1 (en) | 2012-09-12 |
ES2407056T3 (en) | 2013-06-11 |
MX2007005476A (en) | 2008-04-22 |
KR20070090905A (en) | 2007-09-06 |
EP1809306A1 (en) | 2007-07-25 |
CA2587029C (en) | 2013-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005302085B2 (en) | Copper containing materials for treating wounds, burns and other skin conditions | |
US9931283B2 (en) | Methods and materials for skin care | |
US10350219B2 (en) | Antimicrobial compositions and methods of making the same | |
US20150209386A1 (en) | Copper Containing Materials for Treating Wounds, Burns and Other Skin Conditions | |
CN101087631B (en) | Method and material for protecting skin | |
IL171852A (en) | Cosmetic methods and materials for skin care | |
CN101087617A (en) | Method and material for curing wound, burn and skin disease | |
NZ714540B2 (en) | Antimicrobial compositions and methods of making the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2007539711 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3328/DELNP/2007 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2007/005476 Country of ref document: MX Ref document number: 2587029 Country of ref document: CA Ref document number: 2007/03628 Country of ref document: ZA Ref document number: 2005302085 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005803225 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 555072 Country of ref document: NZ |
|
ENP | Entry into the national phase |
Ref document number: 2005302085 Country of ref document: AU Date of ref document: 20051107 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020077012748 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580044672.1 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2005803225 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11667182 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020137033264 Country of ref document: KR |